References

Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature

10.1007/s15010-020-01483-8 · 2020 · External reference

Epidemiological Study on Mycoplasma pneumoniae and Chlamydia pneumoniae Infection of Hospitalized Children in a Single Center During the COVID-19 Pandemic

10.3389/fcimb.2022.843463 · 2022 · External reference

Assessment of Respiratory Bacterial Coinfections Among Severe Acute Respiratory Syndrome Coronavirus 2-Positive Patients Hospitalized in Intensive Care Units Using Conventional Culture and BioFire, FilmArray Pneumonia Panel Plus Assay

10.1093/ofid/ofaa484 · 2020 · External reference

Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment

10.1016/j.jmii.2022.09.006 · 2022 · External reference

The Assessment of Multiplex PCR in Identifying Bacterial Infections in Patients Hospitalized with SARS-CoV-2 Infection: A Systematic Review

10.3390/antibiotics12030465 · 2023 · External reference

The lower respiratory tract microbiome of critically ill patients with COVID-19

10.1038/s41598-021-89516-6 · 2021 · External reference

Evaluation of Laboratory Results with Data from Bio-Speedy Respiratory Panel 2 in Nasopharyngeal Swab Specimens of COVID-19-Suspected Patients Having PCR(-) Results

10.33808/clinexphealthsci.1117146 · 2023 · External reference

Secondary Bacterial Infections Associated with Influenza Pandemics

10.3389/fmicb.2017.01041 · 2017 · External reference

Microbial coinfections and superinfections in critical COVID-19: a Kenyan retrospective cohort analysis

10.1016/j.ijregi.2021.09.008 · 2021 · External reference

SARS-CoV-2, other respiratory viruses and bacteria in aerosols: Report from Kuwait's hospitals

10.1111/ina.12871 · 2021 · External reference

SARS-CoV-2-related pneumonia cases in pneumonia picture in Russia in March-May 2020: Secondary bacterial pneumonia and viral co-infections

10.7189/jogh.10.020504 · 2020 · External reference

Bacterial coinfections in COVID-19: an underestimated adversary

10.4415/ann_20_03_14 · 2020 · External reference

Bacterial co-infections with SARS-CoV-2

10.1002/iub.2356 · 2020 · External reference

National Early Warning Score (NEWS) 2: Standardising the Assessment of Acute-Illness Severity in the NHS. Updated Report of a Working Party

2017 · External reference

Current Status of Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) in Clinical Diagnostic Microbiology

10.3390/molecules25204775 · 2020 · External reference

Laboratory diagnosis of community-acquired pneumonia

2014 · External reference

ggplot2: Elegant Graphics for Data Analysis

10.1007/978-3-319-24277-4_9 · 2016 · External reference

cooccur: Probabilistic Species Co-Occurrence Analysis in R

10.18637/jss.v069.c02 · 2016 · External reference

Frequency of Mycoplasma pneumoniae and Chlamydophila pneumoniae co-infections in COVID-19 inpatients

2024 · External reference

The dynamic lung microbiome in health and disease

10.1038/s41579-022-00821-x · 2023 · External reference

The prevalence of early- and late-onset bacterial, viral, and fungal respiratory superinfections in invasively ventilated COVID-19 patients

10.1002/jmv.27548 · 2022 · External reference

The Prevalence and Impact of Coinfection and Superinfection on the Severity and Outcome of COVID-19 Infection: An Updated Literature Review

10.3390/pathogens11040445 · 2022 · External reference

Bacterial co-infection in COVID-19: a call to stay vigilant

10.7717/peerj.18041 · 2024 · External reference

Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA

10.1002/jmv.26026 · 2020 · External reference

Role of Pyroptosis in Gynecological Oncology and Its Therapeutic Regulation

10.3390/biom12070924 · 2022 · External reference

Clinical and Epidemiologic Features of Mycoplasma pneumoniae Infection Among Adults Hospitalized with Community-acquired Pneumonia

10.7150/ijms.99233 · 2024 · External reference

COVID-19 mimics on chest CT: a pictorial review and radiologic guide

10.1259/bjr.20200703 · 2021 · External reference

Diagnostic value of ground-glass opacity in suspected coronavirus disease 2019 patients: A meta-analysis

10.4103/rid.rid_7_21 · 2021 · External reference

Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia

10.1186/s12879-020-05356-1 · 2020 · External reference

Association of mortality and recent Mycoplasma pneumoniae infection in COVID-19 patients

10.1002/jmv.26467 · 2021 · External reference

Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features

10.1016/j.jinf.2021.01.009 · 2021 · External reference

The Severity of the Co-infection of Mycoplasma pneumoniae in COVID-19 Patients

10.7759/cureus.24563 · 2022 · External reference

Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study

10.1093/ofid/ofaa578 · 2020 · External reference

Comparison of the respiratory tract microbiome in hospitalized COVID-19 patients with different disease severity

10.1002/jmv.28002 · 2022 · External reference

Rothia mucilaginosa pneumonia in an otherwise immunocompetent adult with COVID-19

10.1016/j.chest.2023.07.1016 · 2023 · External reference

Co-infection with respiratory pathogens among COVID-2019 cases

10.1016/j.virusres.2020.198005 · 2020 · External reference

Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance

10.1186/s40168-022-01342-8 · 2022 · External reference

Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 Pandemic

10.3390/microorganisms10050907 · 2022 · External reference

Increase in invasive Haemophilus influenzae serotype A infections during the COVID-19 pandemic in New South Wales, Australia

10.1016/j.pathol.2024.02.013 · 2024 · External reference

Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium

10.1016/s2589-7500(23)00108-5 · 2023 · External reference

Worldwide prevalence of microbial agents' coinfection among COVID-19 patients: A comprehensive updated systematic review and meta-analysis

10.1002/jcla.24151 · 2022 · External reference